Gregory G. Freitag
Independent DirectorMr. Gregory G. Freitag, Esq., JD, CPA, has been an Independent Director of ZyVersa Therapeutics, Inc. since January 2023. He is currently the Chief Executive Officer of EmployRx, Inc. and the Chief Executive Officer of FreiMc LLC, a healthcare and life science consulting and advisory firm he founded in May 2009 that provides strategic guidance and business development advisory services. Mr. Freitag was also a member of the board of directors of PDS Biotechnology Corporation (NASDAQ: PDSB), a clinical-stage immunotherapy company, since March 15, 2019 until October 18, 2026 and serves as a Director of Chumbo Holdings, Inc. Mr. Freitag served as a Director of AxoGen, Inc. from September 2011 until June 5, 2024 and was Axogen’s Special Counsel from June 2020 until his retirement in April 2021. He served as General Counsel at AxoGen, Inc. from September 2011 until December 2019 and as Chief Financial Officer from September 2011 to May 2014 and again from August 2015 to March 2016. He was Senior Vice President of Business Development at AxoGen, Inc. from May 12, 2014, to October 29, 2018. Previously, Mr. Freitag served as Chief Executive Officer and Chief Financial Officer of LecTec Corp. from June 2010 to September 2011 and as a Director from June 2010 through September 2011. He co-founded HTS Biosystems, Inc., serving as its Chief Executive Officer from March 2000 to 2005 and as President since its inception. He was Chief Operating Officer of Quantech Ltd. from June 1997 to January 2001, Chief Financial Officer and Secretary from December 1995 to December 2000 and General Counsel of Quantech, Ltd. Prior to joining Quantech, he was a Lawyer with the Minneapolis, Minnesota law firm of Fredrikson & Byron, P.A., practicing in the corporate, securities and merger and acquisition areas of law. Mr. Freitag worked in business development at Guidant Corporation from July 2005 to January 2006 and served as Director of Business Development at Pfizer Health Solutions, a former subsidiary of Pfizer, Inc., from January 2006 to May 2009. He has served as Director of Pressure BioSciences, Inc. from July 27, 2010, to July 2012, Director of HTS Biosystems and Director of Quantech Ltd. since April 2001. He serves as the Chairman of People Serving People and is also a Director of the Foundation Board of HealthEast Care System. Mr. Freitag is a Certified Public Accountant. He holds a B.A. degree in Business and Economics and Law & Society from Macalester College and a J.D. degree from the University of Chicago. Mr. Freitag was selected to serve on the Board and as the chair of the Company’s Audit Committee because of his proven leadership and experience as a senior-level executive, his particular knowledge of public companies, including reporting, compliance and financial markets related thereto, his finance management and legal expertise, his former position as a public company chief financial officer and experience in the life sciences sector.
Positions
- Company NameZyVersa Therapeutics, Inc.Stock CodeZVSAPositionIndependent Director
